RAMQ has covered more than $280 million in Ozempic claims
The RAMQ says criteria for reimbursement are strict and the payments have been for the treatment of Type 2 diabetes, not to stimulate weight loss.
Ozempic, globally renowned as a weight loss tool, continues to be increasingly prescribed in Quebec, with the province's Régie de l'assurance maladie du Québec (RAMQ) saying it has thus far covered more than $280 million in claims. Read More